Bonjesta- the first dual release combination of doxylamine-pyridoxine for morning sickness
Motherisk Intl J 2020;1;19 Bonjesta- the first dual release combination of doxylamine-pyridoxine for morning sickness Gideon Koren, Rana Cohen, Adelson School of Medicine, Ariel University and Motherisk Israel Program Question: The delayed release of doxylamine/ pyridoxine (Diclegis®) works well in many of my patients with morning sickness. The problem I have is that it…
Read MoreTHE CONTROVERSY OVER THE SAFETY OF ONDANSETRON IN PREGNANCY- WHY DOES IT CONTINUE?
Motherisk Int J 2020;1:10 Gideon Koren MD(1-2), Yusuf Cem Kaplan MD(3) Adelson Faculty of Medicine, Ariel University(1), Motherisk Israel Program (2) and Terafar – Izmir Katip Celebi University Teratology Information Center, Turkey (3) Address for Correspondence: Adelson Faculty of Medicine, Ariel University, Ariel Israel 40700 gidiup_2000@yahoo.com Acknowledgement: GK serves as a paid…
Read MoreHyperemesis Gravidarum- A Previously Unrecognized Human Teratogen
Motherisk Int J 2020;1:3 Asher Ornoy and Matitiyahu Berkovitch MD Hebrew University and Tel Aviv University Abstract: Question: Does hyperemesis gravidarum pause (HG) neurodevelopmental risk to the fetus? Answer: Recent studies have suggested that in HG the baby is at an increased risk for developmental delay and neurobehavioral risks, such as ADHD. These are…
Read MoreCannabis for Hyperemesis Gravidarum; A Risk: Benefit Balance
Motherisk Int J 2020;1:7 Rana Cohen BSc Pharm, Mati Berkovitch MD Motherisk Israel Program and Ariel University Faculty of Medicine Abstract Question I see increasing reports in the social media of American women with hyperemesis gravidarum reporting on beneficial effects of cannabis in hyperemesis. What about the fetal risks of cannabis? Answer: Excellent question.…
Read More